Dr. Elizabeth Roberts -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Elizabeth Roberts, a Oncology physician based in Syracuse, NY. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Elizabeth Roberts has received $24,843.72 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Elizabeth Roberts has received a total of $24,843.72 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $24,843.72 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Elizabeth Roberts's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Consulting Fees$24,843.72Advisory board participation, clinical consulting, and expert opinion services

The largest payment category for Dr. Elizabeth Roberts is Consulting Fees, accounting for 100% ($24,843.72) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Elizabeth Roberts. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Pfizer Inc$24,843.721

Dr. Elizabeth Roberts has a financial relationship with Pfizer Inc, receiving $24,843.72 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Elizabeth Roberts's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Elizabeth Roberts has received $24.8K across 1 pharmaceutical payments as a Oncology physician in Syracuse, NY. Top paying companies include Pfizer Inc ($24.8K). Dr. Roberts received a single payment of $24,844 in 2026, indicating a significant, isolated engagement. The entire payment originated from Pfizer Inc., suggesting a focused relationship with this pharmaceutical company. The payment was categorized as 'consulting,' implying a role in advisory or expert services.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Elizabeth Roberts is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Consumers should be aware that physicians may receive payments from pharmaceutical companies for services like consulting, which can inform their medical practice. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Elizabeth Roberts Compares to Other Oncology Physicians

Oncologists in Syracuse, NY, typically engage with pharmaceutical companies for various services, with payment amounts varying based on the nature and duration of the engagement.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Elizabeth Roberts in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Pfizer Inc$24,843.72consultingN/A2026-01-01Not Assessed

Frequently Asked Questions About Dr. Elizabeth Roberts's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Elizabeth Roberts received?

Elizabeth Roberts has received a total of $24.8K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Elizabeth Roberts taking too much pharma money?

Elizabeth Roberts has received $24.8K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Oncology), the types of payments, and how they compare to peers. The largest payment category is consulting ($24.8K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Elizabeth Roberts?

The top pharmaceutical companies paying Elizabeth Roberts are: Pfizer Inc ($24.8K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Elizabeth Roberts receive?

Elizabeth Roberts's payments by type: consulting: $24.8K. Consulting fees suggest active advisory roles with pharmaceutical companies.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Elizabeth Roberts's payments compare to other Oncology doctors?

To compare, look at the total amount ($24.8K), number of payments (1), and the types of payments received. Oncology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Elizabeth Roberts's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1482856581). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Elizabeth Roberts's pharma payment profile?

The doctor's payment profile is highly concentrated, with 100% of the total amount coming from a single company (Pfizer Inc.). Elizabeth Roberts has received $24.8K in total pharma payments.

How does Elizabeth Roberts compare to peers in Oncology?

Oncologists in Syracuse, NY, typically engage with pharmaceutical companies for various services, with payment amounts varying based on the nature and duration of the engagement.

Are Elizabeth Roberts's pharma relationships typical for Oncology?

The single payment received is substantial, making up the entirety of the reported payments.

What should patients of Elizabeth Roberts know about these payments?

Consumers should be aware that physicians may receive payments from pharmaceutical companies for services like consulting, which can inform their medical practice.

What patterns are visible in Elizabeth Roberts's payment history?

The data reflects a single transaction in 2026, offering a limited snapshot of the doctor's payment history.

Understanding This Doctor Payment Report

This transparency report for Dr. Elizabeth Roberts is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Elizabeth Roberts's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Elizabeth Roberts and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.